RT Journal Article
SR Electronic
T1 Efficacy of cognitive behavioral therapy on non-motor symptoms and quality of life in Parkinson’s disease: A systematic review and meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.12.20128967
DO 10.1101/2020.06.12.20128967
A1 Fangyi Luo
A1 Mengfei Ye
A1 Tingting Lv
A1 Baiqi Hu
A1 Jiaqi Chen
A1 Junwei Yan
A1 Anzhe Wang
A1 Feng Chen
A1 Ziyi He
A1 Zhinan Ding
A1 Jian Zhang
A1 Hui Gao
A1 Chao Qian
A1 Zheng Liu
YR 2020
UL http://medrxiv.org/content/early/2020/06/14/2020.06.12.20128967.abstract
AB Objective The aim of this study was to perform a quantitative analysis to evaluate the efficacy of cognitive behavioral therapy (CBT) on non-motor symptoms and its impact on quality of life (QOL) in Parkinson’s disease (PD).Methods We searched for randomized controlled trials in three electronic databases. Twelve studies, including 358 patients with PD, met the inclusion criteria. We determined the pooled efficacy by standard mean differences and 95% confidence intervals, using I2 to reveal heterogeneity.Results The result showed CBT had a significant effect on depression [-0.94 (95% CI, -1.25 to -0.64, P < 0.001)] and anxiety [-0.78 (95% CI, -1.05 to -0.50, P < 0.001)]. Moderate effect sizes were noted with stress [-0.60 (95% CI, -1.06 to -0.14, P = 0.01)] and sleep disorders [-0.44 (95% CI, -0.74 to -0.15, P = 0.003)]. There was no evident impact of CBT on fatigue or QOL. We found an intervention period > 8 weeks was advantageous compared with < 8 weeks, and CBT intervention was more effective than CBT developmental therapy.Conclusion We found that CBT in patients with PD was an efficacious therapy for some non-motor symptoms in PD, but not efficacious for fatigue and QOL. These results suggest that CBT results in significant improvement in PD and should be used as a conventional clinical intervention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the National Natural Science Foundation (Nos. 81560059 and 81760058), Zhejiang Medical Health Science and Technology Project (No. 2019328893), the Scientific Research Fund of Shaoxing University (No. 20125025), and the National Training Program of Innovation and Entrepreneurship for College Students (No. 2017R10349001).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our data are derived from the outcome of other randomized controlled trials, so there are no ethical issue involved.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have confirmed.